Deerfield Management

Displaying 1 - 8 of 8

Vanderbilt scientists, research translation experts attend CMT Global Research Convention

Vanderbilt scientists, research translation experts attend CMT Global Research Convention

Related Categories: 
Health and Medicine Research Ancora Ancora Innovation Biochemistry Bruce Carter Charcot-Marie-Tooth disease charles sanders Deerfield Management Margaret Reed OVPRI School of Medicine Basic Sciences vanderbilt brain institute

Vanderbilt and Deerfield Management celebrate Ancora Innovation, a collaboration for accelerating drug discovery, potential life-changing therapeutics

Vanderbilt and Deerfield Management celebrate Ancora Innovation, a collaboration for accelerating drug discovery, potential life-changing therapeutics

Related Categories: 
Ancora Ancora Innovation C. Cybele Raver Daniel Diermeier Deerfield Management John Kuriyan Office of the Provost OVPR OVPRI Padma Raghavan

Vanderbilt-Ancora partnership advances research for rare form of epilepsy 

Vanderbilt-Ancora partnership advances research for rare form of epilepsy

Related Categories: 
Press release Research Academic Strategic Plan Ancora Arts and Science Basic Sciences David Weaver Deerfield Management Discovery Vanderbilt epilepsy Eric Delpire Institute of Chemical Biology Office of the Provost OVPRI Padma Raghavan pharmacology and chemistry VUMC

Deerfield/Cure Lecture Series in Partnership with Ancora Innovation “The Discovery of New Therapeutics Drug Development: A Three-Part Series”

Deerfield/Cure Lecture Series in Partnership with Ancora Innovation “The Discovery of New Therapeutics Drug Development: A Three-Part Series”

Related Categories: 
drug development The Discovery of New Therapeutics Drug Development: A Three-Part Series CURE Deerfield Cure Lecture Series Ancora Innovation Deerfield Management

Vanderbilt-discovered drug candidate for Parkinson’s disease enters clinical trials

Vanderbilt-discovered drug candidate for Parkinson’s disease enters clinical trials

Related Categories: 
Appello Basic Sciences clinical trial clinical trials Craig Lindsley Craig W. Lindsley WCNDD Deerfield Management Research Jeffrey Conn P. Jeffrey Conn Parkinsons Parkinson’s disease Warren Center for Neuroscience Drug Discovery Appello Pharmaceuticals

Vanderbilt-Ancora partnership advances research for Charcot-Marie-Tooth disease

Vanderbilt-Ancora partnership advances research for Charcot-Marie-Tooth disease

Related Categories: 
Research Academic Strategic Plan Bruce Carter Ancora Basic Sciences Biochemistry Chuck sanders charles sanders CTTC Deerfield Management Office of the Provost OVPR Padma Ragahavan vanderbilt brain institute

Ancora announces major funding awards to support Vanderbilt drug discovery research

Ancora announces major funding awards to support Vanderbilt drug discovery research

Related Categories: 
Ancora Deerfield Management Deerfield Carrie Jones Susan Wente Padma Raghavan Ancora Innovation Drug Discovery Innovation Craig Lindsley Vanderbilt Center for Neuroscience Drug Discovery

Vanderbilt licenses compound to Nashville’s Appello to advance Parkinson’s therapies

Vanderbilt University has signed a licensing agreement with Nashville-based start-up Appello Pharmaceuticals, Inc. to advance novel compounds developed by researchers in the Vanderbilt Center for Neuroscience Drug Discovery (VCNDD) for the treatment of Parkinson’s disease.

Related Categories: 
Research Appello Deerfield Management pharmaceutical  Vanderbilt Center for Neuroscience Drug Discovery VCNDD Parkinson's Disease parkinson's